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Abstract 15 
This study addresses the regulation of the Interleukin 1 (IL1) system in the murine uterine 16 
luminal epithelium (LE) and stroma by leukemia inhibitory factor (LIF). Using RT-PCR we 17 
compared expression of Il1a, Il1b, Il1rn, Il1r1 and Il1r2 during the pre- and peri-implantation 18 
periods of pregnancy in wild type (wt) and LIF null LE and stroma. In wt LE, Il1a transcripts 19 
were down-regulated on day (D) 4am with renewed expression by D4pm. In Lif -/- LE there was 20 
a gradual decrease in expression from D2 which became undetectable by D6.  Il1b and Il1r1 21 
expression were similar in wt and null mice, but Il1rn expression was almost completely lost 22 
during the peri-implantation period in Lif -/- LE. In the stroma Il1a was sharply down-regulated 23 
on D4 am reappearing on D4 pm, but in the null mice was only expressed on D3 and D5.  24 
Stromal Il1r1 and Il1r2 were also misregulated.  Il1rn showed constitutive expression in null 25 
stroma in contrast to the loss of expression on D4am in the wt mouse.  In Lif deficient mice, 26 
immunostaining indicated a reduction of endometrial IL1A at the time of implantation and of 27 
Il1B in stroma. LE-stromal co-culture revealed that LIF stimulated apical secretion of both IL1A 28 
and PTGES2 by LE cells without affecting basal secretion of IL1A and with only a small effect 29 
on basal PTGES2 secretion. We conclude that Il1a and Il1rn in LE and Il1a, Il1rn and Il1r1 in 30 
stroma are regulated by LIF which stimulates apical secretion of IL1A by LE. 31 
Introduction 32 
Embryo implantation involves a complex and dynamic interaction between the trophoblast, the 33 
uterine epithelium and the stroma which must occur within a specific temporal ‘window’ during 34 
which the uterine endometrium is receptive to the embryo.  Although it is well established that 35 
this ‘window of implantation’ is primarily controlled by the steroid hormones estrogen and 36 
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progesterone (P4) [1;2], recent evidence has shown that a plethora of other molecules including 37 
growth factors and cytokines mediate and  modulate the actions of these steroid hormones [3;4].  38 
Uterine LIF is expressed in two transient peaks during early pregnancy.  Firstly, on day 1 (D1) of 39 
pregnancy (vaginal plug = D1 of pregnancy) LIF expression is stimulated by ovulatory estrogen 40 
in both luminal and glandular epithelium. Secondly, on D4, nidatory estrogen stimulates 41 
expression of both Lif mRNA and protein in the glandular epithelium (GE) [5-7].  This second 42 
peak of LIF expression is essential for successful embryo implantation into the uterus on the 43 
evening of D4 of pregnancy [8]. The cellular target of LIF in the uterus during pregnancy appears to 44 
be the luminal epithelium (LE) and Lif receptor (Lifr) transcripts and protein have been found to be 45 
present predominantly in the LE during D3-D5 of pregnancy [9;10].  It has been known for some 46 
time that uteri of Lif deficient mice are unable to support embryo implantation [6].  However, Lif 47 
-/- blastocysts can undergo implantation when transferred into pseudopregnant recipients and 48 
develop to term demonstrating that the implantation defect is maternal. Rescue of implantation 49 
can be achieved by exogenous delivery of LIF on D4 of pregnancy in the homozygous mutants 50 
[6;8;11]. The importance of LIF for successful embryo implantation in the mouse may be of general 51 
significance to all mammals and other species.  Indeed, increased levels of LIF during pregnancy 52 
have been shown to be conserved in several species including humans and rhesus monkeys [12-53 
15], while low levels of Lif have been correlated with infertility in women [16-19].  54 
Furthermore, the uteri of Lif deficient mice do not undergo decidualisation, a process involving 55 
the differentiation of the uterine stroma essential to support the implanting embryo [6-8].  56 
Decidualisation is triggered by a number of molecules and is first discerned by an increase in 57 
vascular permeability at the site of implantation [1;20]. Amongst the best candidates for roles in 58 
the initiation of decidualisation are prostaglandins (PGs), which increase at the time of 59 
implantation. PTGES2 is a central PG involved in the initiation of uterine vascular permeability 60 
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[21-23]. PGs are produced by both uterine epithelial and stromal cells and their synthesis is 61 
induced by Interleukin 1 (Il1), also produced by the uterine epithelium, as well as by other cell 62 
types including macrophages [24].  The IL1 system is composed of two agonists IL1A and IL1B, 63 
one antagonist IL1RN and two membrane bound receptors, IL1 receptor type one (IL1R1) and 64 
type two (IL1R2) [25;26].  Endogenous control of secreted IL1 activity is achieved by regulation 65 
of IL1 synthesis and processing and release from intracellular and membrane bound stores [26]. 66 
This control of IL1 bioavailability is further regulated by a unique receptor antagonist (IL1RN), 67 
which binds with high affinity to IL1 receptors thus preventing access by IL1 ligands and 68 
inhibiting signalling [27].  In mouse, IL1R1 protein is reported to be induced in uterine LE cells 69 
during the preimplantation period and subsequent blockade of IL1 signalling by injection of 70 
IL1RN during early pregnancy prevents attachment of the blastocyst to the LE [28;29].  71 
 72 
Epithelial derived IL1A has been previously reported to upregulate the synthesis of PTGES2 and 73 
PGF2α in mouse and rat uterine stromal cells [30;31] and other studies in vitro have shown that 74 
IL1A increases levels of mRNA for Ptgs2 (a rate limiting enzyme for PG synthesis) in rat uterine 75 
stromal cells [32].  Evidence from in vivo studies has demonstrated that mRNA and protein 76 
levels of PTGS2 are reduced in the uterine stroma of Lif deficient mice at the implantation site 77 
[7;33].  We have shown, however, that LIF does not directly promote the synthesis of PTGES2 78 
by uterine stromal cells in vitro suggesting that PTGES2  is not a direct target of LIF here [34]. 79 
In human endometrial epithelial cells, IL1B upregulates LIFR and this effect is abrogated by 80 
inhibition of IL1R1 [35]. This suggests that in human and murine endometrium it is likely that 81 
feedback loops exist between LIF and IL1 in uterine epithelial cells. Together with the reduction 82 
of PTGS2 expression at the implantation site in Lif -/- females these findings support a signalling 83 
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cascade involving LIF induction of IL1 in the LE that triggers the onset of the decidual response 84 
via PGs.   Therefore using a co-culture system we have investigated the effects of LIF on IL1A 85 
production and gene expression by cultured mouse uterine LE and stromal cells in a 86 
physiologically relevant model. We have also shown that IL1 and its associated molecules are 87 
precisely regulated in LE and stroma during early pregnancy in vivo. Moreover the temporal 88 
sequence of changes in Il1 related gene expression (specifically Il1a and Il1rn) during uterine LE 89 
development for implantation is seriously altered in Lif -/- mice indicating that a close 90 
relationship exists between LIF and IL1A in the regulation of endometrial cells as demonstrated 91 
in vitro.  92 
Materials and methods 93 
Animals 94 
All mice were maintained under conditions in accordance with the UK Home Office as in 95 
Fouladi-Nashta et al., [7] and procedures were in accordance with our UK Home Office licence.  96 
MF1 (wild type outbred) female mice (Harlan Olac Ltd, Bicester, UK) between 7-9 weeks of age 97 
were placed with MF1 males overnight for mating and pregnancy was confirmed by the presence 98 
of a vaginal plug (D1 of pregnancy).  MF1 female mice used for in vitro culture were induced to 99 
ovulate by an intraperitoneal injection of a single dose of 5 IU eCG (Intervet, Milton Keynes, 100 
UK), followed by a single injection of 5IU hCG (Intervet) 48h later.  Mating was confirmed by 101 
the observation of a vaginal plug the following morning.  Mice were killed by cervical 102 
dislocation on D2 of pregnancy (48h following hCG) and uterine tissues processed as below.  103 
The Lif -/- MF1 founder mice were provided by Dr Andrew Sharkey (University of Cambridge) 104 
from an original colony generated at the Institute for Stem Cell Research, University of 105 
Edinburgh [36]. Since Lif -/- females are infertile, propagation of Lif -/-mice was achieved by 106 
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breeding from null males and heterozygote females as previously described [7;37]. Genotyping 107 
for identification of Lif -/- mice was carried out by PCR on DNA samples from progeny 108 
following weaning as previously reported by us [7;37]. Animals were killed by cervical 109 
dislocation on the required day of pregnancy and uterine tissue processed as detailed below.  110 
Uteri were harvested in the morning between 0900h-1000h and on D4 also in the evening 111 
between 2100h-2200h. 112 
Reagents 113 
All reagents were purchased from Sigma (Dorset, UK) unless otherwise indicated.  Primary 114 
antibodies were used as follows: Goat anti-mouse IL1A (2µg/ml; R&D systems, Oxfordshire, 115 
UK), rabbit anti-mouse IL1B (1µg/ml; Santa Cruz Biotechnology, Heidelberg, Germany), 116 
monoclonal 11-5F against desmoplakin (1:10; courtesy of Prof. D Garrod, University of 117 
Manchester), rabbit anti-mouse TJP1 (1µg/ml; Zymed, Cambridge UK), rat anti-mouse f4/80 118 
(Serotec, Oxford, UK), fluorescein isothiocyanate (FITC) conjugated donkey anti goat, rat or 119 
rabbit IgG secondary antibodies were used at 4µg/ml (Jackson Immunoresearch Laboratories, 120 
PA, USA) or alternatively an Alexa 488 conjugated donkey anti goat IgG (10µg/ml; Molecular 121 
Probes, Invitrogen, Paisley, UK) or a biotinylated goat anti rabbit IgG (7.5µg/ml; Vector 122 
Laboratories, Peterborough, UK ) was used. Texas red-X phalloidin was used at 1:50 (Molecular 123 
Probes). Normal goat serum (NGS) was used at a 1:20 dilution to minimise non-specific binding.  124 
Mouse IL1A used as the standard in ELISA was purchased from Chemicon, (Hampshire, UK).  125 
For use in culture LIF was obtained courtesy of Dr A Vernallis (Aston University) and its 126 
activity calibrated by the proliferation response of BAF cells (gift from Dr A Vernallis).  The 127 
LIF inhibitor (hLIF-05), a LIFR antagonist was used at 10 times the concentration of 128 
supplemented LIF [34;38;39]. 129 
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 Uterine epithelial cell layer dissociation for RNA extraction 
Uterine horns were dissected from wt or Lif null females on D2-6 of pregnancy and the LE cell 130 
‘tube’ dissociated from the stroma and gently squeezed out according to [40]. The uterine horns 131 
were then slit longitudinally and stromal cells scraped from LE depleted horns using a cell 132 
scraper (BD Biosciences, Oxfordshire, UK). The samples were centrifuged at 3000xg for 3 mins. 133 
Total RNA was isolated from the cells using the RNeasy Kit, (Qiagen, West Sussex, UK) 134 
according to manufacturer’s instructions. Briefly, the tissue was lysed by drawing 10 times 135 
through a 21 gauge needle (BD Biosciences) in either 350µl (epithelial extracts) or 600µl 136 
(stromal extracts) of guanidine isothiocyanate (GITC) and 0.1% (v/v) β mercaptoethanol. To 137 
ensure complete homogenisation of the tissue, the samples were added to a Qiashredder column 138 
(Qiagen) following manufacturer’s instructions. RNA preparations were quantified by 139 
absorbance at 260nm (A260) using a Nanodrop spectrophotometer (Labtech Intl., E. Sussex, UK) 140 
or Genequant (Amersham Bioscience, Amersham, UK) spectrophotometer. Purity was calculated 141 
from the A260/A280 ratio.   142 
Isolation of total RNA from cultured uterine epithelial and stromal cells 143 
The stromal cells were detached from the wells using a cell scraper (Corning) and the cell 144 
suspensions were centrifuged at 1000g for 5 min. The supernatant culture medium was removed 145 
and the pellet was stored in liquid nitrogen. The LE cells attached to the membranes were 146 
transferred directly to the lysis buffer. RNA was isolated from all samples using RNeasy mini kit 147 
(Qiagen, West Sussex, UK) as above.  148 
Reverse Transcription-Polymerase Chain Reaction 149 
Relative changes in Il1a, Il1b, Il1rn, Il1r1 and Il1r2 mRNA were examined in uterine LE and 150 
stromal isolates on D2-6 of pregnancy in wt and Lif null females using reverse transcription 151 
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polymerase chain reaction (RT-PCR). Samples from a minimum of 3 independent animals were 152 
used in each case  Changes in PCR products obtained for Il1 were normalised by comparison 153 
with an endogenous house keeping gene, glyceraldehyde-3-phosphate dehydrogenase (Gapdh), 154 
expression of which has been shown to be consist in the uterus [40]. Briefly, 2μg total RNA from 155 
each sample was reverse transcribed using Superscript II first strand cDNA synthesis 156 
(Invitrogen, Paisley, UK) following manufacturer’s instructions with omission of reverse 157 
transcriptase run in parallel in all reactions.  PCRs were assembled to a final volume of 25µl 158 
containing 0.5µl of cDNA template, 10pmol (final concentration) primers and Red Taq PCR 159 
Buffer reaction mix (Sigma). No template and a reverse transcriptase negative control were 160 
assembled in parallel. Optimal annealing temperatures and cycle number are shown in table 1. 161 
Cycle conditions were as follows: initial denaturation at 94°C for 1 min, then cycles of the 162 
following, 30s at 94°C, annealed for 30s at a temperature determined as optimum and extended 163 
at 72°C for 30s. PCR products were resolved on a 2% (w/v) agarose gel and the results 164 
visualised under UV trans-illumination (GRI, Essex, UK).  PCRs were also taken to saturation 165 
(40 cycles) to determine if transcripts were weakly expressed or absent.  The PCR products were 166 
verified by automated capillary gel electrophoresis by Manchester Sequencing Services using an 167 
ABI Prism 377 sequencer (Applied Biosystems, Cheshire, UK) and products confirmed by a 168 
BLAST search. 169 
Immunolocalisation of IL1A/IL1B 170 
Uterine horns were fixed in either 4% paraformaldehyde (PFA) for 4h at room temeperature or in 171 
Carnoy’s fixative for 30 mins at room temperature and dehydrated through an ethanol series 172 
before being embedded in paraffin wax and sectioned. Deparaffinised sections were either 173 
processed for antigen retrieval by microwave treatment (750W) with TEG buffer (1.2 g/l Tris, 174 
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0.190 g/l EGTA in distilled water, pH: 9) (IL1A) as previously described [7] or, following 175 
exposure to 0.3% (v/v) hydrogen peroxide in methanol for 12 mins, subjected to antigen retrieval 176 
with 0.01M citrate buffer (pH 6.0) for 6 minutes (IL1B).  After cooling, non-specific binding 177 
was blocked in 10% (v/v) NGS and 0.1% (w/v) BSA in PBS (blocking solution).   178 
For immuno-peroxidase staining (IL1B), endogenous biotin was blocked using an avidin/biotin 179 
blocking kit as per manufacturers’ instructions (Vector Laboratories).  The primary rabbit anti-180 
IL1B or irrelevant control antibodies were diluted 1:50 in blocking solution and incubated 181 
overnight at 4ºC. Following washing, the sections were incubated in the appropriate biotinylated 182 
secondary antibody for 45 mins at room temperature.  ABC reagent (Vector Laboratories) was 183 
applied to the sections for 30 mins and positive immunoreactivity was detected using a 184 
diaminobenzidine peroxidase (DAB) substrate kit (Vector Laboratories).  Nuclei were 185 
counterstained with Harris’ haematoxylin and sections mounted in a permanent mountant 186 
(CellPath, Newtown, Powys).  To determine macrophage and IL1A immunoreactivity, uterine 187 
tissue from D4 of pregnancy was placed into aluminium foil containers of cryo-embedding 188 
compound OCT (Raymond A Lamb Laboratories, Sussex, UK).  The samples were then flash-189 
frozen in liquid nitrogen and stored at –80 °C.  Serial sections (7μm) were taken using a cryostat 190 
(Leica UK Ltd, Milton Keynes, UK) and fixed for 10 minutes in ice-cold acetone at -20° C.  The 191 
sections were rehydrated in 0.1%w/v BSA, 0.1%v/v Tween20 in PBS.  Normal goat serum 192 
(NGS) at a 1:20 dilution was used to block non specific binding.  The diluted primary antibody 193 
(1:50 for both IL1A and f4/80) was added to each section and left overnight at 4°C.  Following 194 
washing, the sections were incubated with the appropriate fluorescein FITC conjugated 195 
secondary antibody for 45 mins at RT.  The sections were mounted in Vectashield with 1.5µg/ml 196 
DAPI (Vector Laboratories, Peterborough, UK) and stored in the dark at 4°C.  For all 197 
 10
experiments relevant isotypes were used as negative controls and carried out in parallel.  A 198 
secondary antibody only control was also used to check for non specific secondary antibody 199 
binding.   200 
Isolation and culture of uterine luminal epithelial and stromal cells 201 
Briefly fat-trimmed uteri were cut longitudinally to expose the lumen. They were placed in 202 
trypsin dissociation solution (0.5% Type II bovine trypsin and 0.165% pancreatin in Hanks 203 
Balanced Salt Solution (HBSS: Invitrogen) for 1h at 4°C followed by 1h at room temperature. 204 
The medium was removed from the uteri, discarded and replaced with ice cold DNase medium 205 
(1μg/ml DNAse [Type II from bovine pancreas], 10mM MgCl2 and 0.1% fetal calf serum 206 
[HIFCS: Invitrogen] in HBSS) before vortexing for 10 s at medium speed. The supernatant cell 207 
suspension was transferred to a 50 ml Falcon tube on ice. The whole process was repeated and 208 
the supernatants pooled for isolation of LE cells. The remaining uteri were washed with HBSS 209 
and used for isolation and culture of stromal cells as described below. 210 
Isolation and culture of uterine LE cells 211 
Preparation and culture of epithelial cells was as developed by Blissett and Kimber [41] modified 212 
from [42]. The epithelial cell suspension was centrifuged at 200g for 5 min at 4ºC. The 213 
supernatant was removed and the cell pellet was re-suspended in 10 ml ice cold DNAse medium 214 
for 1 min before re-centrifugation. This procedure was repeated 3 times. DNAse medium was 215 
replaced with HBSS and the Falcon tube placed at a 45° angle (15 min on ice) to allow LE cell 216 
plaques to separate under gravity. The supernatant was removed and the epithelial cells re-217 
suspended in 10ml ice cold HBSS. The process was repeated for a total of 4 gravitational 218 
separations before adjusting cell density to 8.0 x 105 cells / ml in LE culture medium [1 :1 Ham’s 219 
F12:Dulbecco’s modified essential medium (DMEM) (Gibco BRL Life Technologies Ltd, 220 
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Paisley UK) containing 0.1% bovine serum albumin (BSA ; Fraction V Albumin, ICN), 221 
100mg/ml pen/strep, 2.5% NuSerum (Collaborative Research Inc, Bedford, UK), 2.5% HIFCS, 222 
15mM Hepes buffer and 200mM L-glutamine].  LE cells were cultured on Cellagen membranes 223 
(ICN-Flow Thame UK) as previously described [43;44]. Cellagen discs were pre-incubated with 224 
culture medium. After pre-incubation, media in the apical compartment was replaced with 250μl 225 
cell suspension and the basal compartment with 450µl LE culture medium (Fig 1a). Cells grown 226 
on these membranes are cuboidal and show a semi-polarised phenotype, intermediate between 227 
the highly polarised LE morphology seen in vivo at D1-3 of pregnancy and the flattened 228 
morphology seen for cells grown on plastic. The transepithelial resistance (TER) of the cultures 229 
was measured using a Millicell -ERS transepithelial resistance meter (Millipore Watford UK).  230 
All cultures used in these experiments had a TER above 400cm2. 231 
Isolation and culture of uterine stromal cells 232 
Uterine stromal cells were isolated and cultured as previously described [34].  Upon removal of 233 
LE from the uterine tissue (see above), ten glass beads were added to the remaining LE denuded 234 
endometrium extract, together with stromal trypsin dissociation solution (0.05% trypsin and 235 
0.02% EDTA (BDH) in HBSS).  The tubes containing cell extracts were incubated for 20 min at 236 
37ºC and vortexed at medium speed for 10s every 10 mins. This was process was repeated by 237 
incubation at room temperature. The content of the tube was passed through a 70μm gauze filter 238 
(Falcon) and the enzymatic digestion stopped (2% Soybean trypsin inhibitor in HBSS) after 239 
filtration. The cell suspension was then centrifuged at 400g for 10min at 4ºC. The pellet was 240 
washed in stromal cell culture medium: 1:1 mixture of DMEM and Ham’s F12 medium 241 
(Invitrogen) supplemented with 1.2g/l of sodium bicarbonate, 100IU/ml penicillin streptomycin 242 
(Invitrogen), 2% Heat Inactivated Fetal Calf Serum (HIFCS, Invitrogen) and centrifuged for 10 243 
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min at 4ºC.  The pellet was re-suspended in culture medium and live cells were assessed by 244 
trypan blue exclusion using a Neubauer haemocytometer. We have already shown that cells 245 
stained with epithelium-specific antibody marker (H001) were less than 2% of cells [34] and 246 
leukocytes were < 1% by 48 h under these conditions.  247 
 Isolated stromal cells were cultured in 24 well dishes (Nunc) at 1.5 x 105 cells/ml in 5% CO2 in 248 
air at 37ºC. Evaluation was undertaken on a minimum of 3 cultures in each case. For co-culture, 249 
uterine stromal cells were cultured in the basal compartment and LE cells introduced on to the 250 
inserts at the time of stromal seeding. Media in both compartments were changed at 48 h and 96 251 
h. Culture media from both compartments were collected and stored at -80°C for IL1A and 252 
PTGES analysis in triplicateAll experiments were repeated on a minimum of 3 separate 253 
occasions.  254 
ELISA for IL1Α 255 
IL1A secretion into the culture media by uterine stromal and LE cells was measured using a 256 
mouse IL1A ELISA module set (BMS611MST; Medsystems Diagnostic GmbH, Vienna, 257 
Austria) according to manufacturer’s instruction. Briefly, Microwell plates (Maxisorb) were 258 
coated with rabbit anti-mouse IL1A (3 μg/ml) overnight at 4°C. Non-specific binding was 259 
blocked with 250μl of assay buffer (5mg/ml % BSA, 0.05% Tween 20 in PBS) for 2 h at room 260 
temperature. Serial dilutions of mIL1 standard protein in PBS were added in duplicate to the 261 
standard wells (for construction of a standard curve). Wells were then incubated with Biotin-262 
Conjugate (1 in 10000) for 2 h at room temperature. They were washed 3 times in wash buffer 263 
(0.05% Tween 20 in PBS), Streptavidin-HRP added and incubated for 1 h at room temperature. 264 
After washing TMP substrate solution (1:2 mixture of H2O2 and Tetramethylbenzidine) was 265 
added and shaken for 20 min in the dark. The enzyme reaction was stopped by 100μl 4Ν 266 
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Sulphuric Acid and the colour intensity read on a microplate reader at 450nm to calculate IL1A 267 
concentrations. 268 
Prostaglandin E radioimmunoassay (RIA) 269 
The concentration of PTGES2 was measured in the culture media as in [34] using Sigma RIA 270 
and standards (0-100pg/ml) prepared in RIA buffer (0.01M PBS, pH 7.4 containing 0.1% BSA 271 
and 0.1% sodium azide). One hundred μl of sample or standards and 500μl of antibody working 272 
solution were added to 1.5 ml Eppendorf tubes, vortexed, incubated for 3 min at 4˚C and then 3H 273 
prostaglandin E (Amersham), diluted in RIA buffer to give 6000 cpm in 700μl, was added. The 274 
tubes were vortexed and incubated for 1h at 4˚C and 200μl cold dextran-coated charcoal 275 
suspension (0.1% dextran, 1% activated charcoal (100-400 mesh) in RIA buffer) added. After 276 
shaking, the tubes were centrifuged at 800g for 15 min at 4˚C and the supernatants transferred 277 
into scintillation vials with 4 ml of scintillation cocktail (Optiphase Hisafe 2, Wallac). 278 
Radioactivity was measured with a ß counter (Wallac-M1214) and the sample concentration 279 
extrapolated from the standard curve. The values were considered reliable only in the logit 280 
interval of ±2.2 when the unlabelled molecules displace between 10 and 90% of maximum 281 
radioactivity bound [45]. 282 
Immunofluorescence staining of junctional proteins in cultured LE cells 283 
Cellagen discs were removed from culture wells and the membranes (carrying LE cells) were 284 
detached from the supports and cut in two pieces. One half of each membrane was used for 285 
isolation of total RNA and the other half was fixed and deposited on a coverslip for 286 
immunofluorescence staining of junctional proteins including Z0-1, desmoplakin as in [7]. 287 
Primary antibodies and controls were as above. The coverslips were incubated for 2h at room 288 
temperature with an appropriate affinity-purified FITC-conjugated secondary antibody (green) 289 
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containing 10μg/ml phalloidin (red), washed, and incubated for 5mins in 5μg/ml bizbenzimide 290 
(Hoescht (33342, blue staining) before mounting in hydrophilic mounting media containing anti-291 
fading reagent, Gelvatol. 292 
RT-PCR for the Il1a in cultured cells 293 
A one-step RT-PCR kit (Qiagen) was used according to the manufacturer’s instructions for RT 294 
and amplification of a 220bp product. One μg of RNA was used for reverse transcription and 295 
PCR over 30 cycles with an annealing temperature of 60˚C and 5 min extension. For experiments 296 
where Il1a mRNA transcripts were compared between different groups, the tubes were removed 297 
from the cycler (Eppendorf) every 2 cycles after the 18th cycle (amplification cycles in the linear 298 
range). Extension was then continued in another machine. The cycle number at which Actb was 299 
first detected was used to normalise for cDNA quantities.    300 
Statistical analysis 301 
Data are presented as mean ± S.E.M. Statistical analysis was performed with the SPSS 13.0 302 
program to carry out a two-way analysis of variance using General Linear model (GLM) 303 
procedure. Effects in the linear model consisted of batch effects and the effects of time and LIF 304 
treatments. A post hoc test was then used to analyse the difference between control and 305 
treatments. Tukey’s test was also used to reveal the differences between each treatment. 306 
Results 307 
Il1 family members are regulated at the transcript level in peri-implantation uterus 308 
Characterisation of Il1a, Il1b, Il1rn, Il1r1 and Il1r2 mRNA expression on D2-D6 of pregnancy 309 
in wt and Lif null females was performed by RT-PCR (Fig 2) on RNA extracted separately from 310 
uterine stromal and LE isolates. Transcript patterns shown are representative of 3 separate 311 
animals at each stage and genotype. 312 
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Both ligands, Il1a and Il1b showed temporal regulation in the uteri of wt mice during early 313 
pregnancy (Fig 2 A,B).  Specifically, transcripts bands were observed on D2 of pregnancy in 314 
both LE and stromal isolates and intensity of bands appeared to then decrease such that on the 315 
morning of D4 of pregnancy (0900h) no transcripts could be detected for Il1a (even when PCRs 316 
were taken to saturation), although a very faint band was seen for Il1b in LE and stroma. 317 
However, by the evening of D4 (2200h), which follows elevated levels of estrogen and LIF, 318 
mRNAs for Il1a and Il1b in both LE and stromal isolates were again detected as seen on D2.  319 
Although, Il1a mRNA was continually expressed up until D6 in both the stroma and LE, Il1b 320 
mRNA was undetectable on D6 in both the LE and stroma, suggesting only transient re-321 
expression on D4 evening and D5 of pregnancy. Moreover the pattern of disappearance of Il1a 322 
on the morning of D4 in wt uteri was not paralleled in the uteri of Lif deficient mice on D2-D6 of 323 
pregnancy.  Il1a mRNA levels appeared to decline progressively from D2 onwards in the LE, 324 
whereas stromal expression of Il1a transcripts were only detected on D3 and D5 of pregnancy in 325 
Lif null mice.  Interestingly, in null females, the pattern of Il1b expression in the LE was parallel 326 
to that seen in wt mice, but stromal expression of Il1b was markedly different.  Obvious stromal 327 
Il1b mRNA signal was detected on D2, D3, D4 morning and D6 of pregnancy but was 328 
undetectable on D4 evening and D5 morning when it was readily detectable in wt stroma.   329 
 
Transcriptional expression of Il1r1 was similar to that seen for Il1b in wt mice where a reduction 330 
in detectable transcripts was identified on the morning of D4 in the stroma and LE (Fig 2D).  On 331 
D5, stromal transcript levels declined and on D6 of pregnancy no transcripts could be detected in 332 
the LE and little in the stroma.  Il1r2 transcripts were consistently detected in the LE from D2 333 
onwards (Fig 2E).  Strong signal for Il1r2 mRNA was seen on the evening of D4 and morning of 334 
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D5 of pregnancy with lowest levels being on D4 morning.  By D5 no stromal expression of Il1r2 335 
mRNA could be detected.  Similar patterns of gene expression were seen in Lif null uteri for 336 
Il1r1 and Il1r2 in the LE to that in wt uteri.  However, stromal expression of Il1r1 mRNA 337 
appeared to be delayed relative to wt, with strong signal on D3, D4 morning and D6, but barely 338 
detectable signals on D2, D4 evening and D5 morning.  In the null uterus Il1r2 transcripts were 339 
only detected in the stroma on D3 and D5.   340 
Il1rn transcripts were consistently expressed throughout D2-D6 of pregnancy in both LE and 341 
stromal isolates from wt mice, with only a transient but marked reduction on D4 morning in the 342 
stromal isolate (Fig 2C).  In LE of Lif nulls, Il1rn mRNA could only be reliably detected on day 343 
2 and D6 of pregnancy. In the stroma however, Il1rn transcripts were consistently expressed 344 
through D2-D6 of pregnancy with no loss of expression on day 4 as in the wt stroma. 345 
IL1A protein expression is reduced in the Lif null uterus at implantation 346 
Transcript analysis revealed that Il1a was regulated differently during early pregnancy in the 347 
uteri of wt and Lif null animals. To investigate whether similar changes occurred in protein 348 
expression, immunohistochemistry was performed on uterine sections from both wt and Lif null 349 
mice (three females for each genotype) on D3-D6 of pregnancy using an antibody to IL1A (Fig 350 
3).  Immunoreactive IL1A was not restricted to the site of embryo attachment/invasion in either 351 
wt or lif null uterus, so sections were stained at and adjacent to the implantation site in wt mice 352 
and presumptive implantation sites in Lif null uteri.  In wt mice, the protein profile was similar to 353 
that seen for mRNA.  On D3 of pregnancy, IL1A protein was identified in LE cells and staining 354 
of a higher intensity was observed in the stroma.  The IL1A positive cells in the stroma 355 
(particularly on D3 of pregnancy) were interspersed with non-stained cells and appeared to be 356 
larger in size than adjacent stromal cells and may be macrophages. Attempts at double staining 357 
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for IL1A and macrophage markers were hampered by the different antigen-antibody 358 
requirements.  However, staining on sequential frozen uterine sections suggested both 359 
macrophages and IL1A protein are in the same areas with distinct expression for IL1A to that of 360 
macrophage distribution (Fig3). By the morning of D4 of pregnancy only very weak staining was 361 
observed in the stroma, but, by the evening of D4, IL1A was detected in the LE and 362 
decidualising stromal cells.  Intense punctate staining could also be seen in the uterus on D5 of 363 
pregnancy, particularly in the decidualised stroma and the embryo itself.  On D6 of pregnancy, 364 
IL1A was still detectable in the primary decidual zone around the embryo and in the outer 365 
decidual cells at the mesometrial pole of the uterus.  In contrast, overall levels of 366 
immunoreactive IL1A appeared greatly reduced in the uteri of Lif null mice compared to wt mice 367 
from D4 morning onwards. Thus on the morning of both D3 and D4 of pregnancy,  IL1A protein 368 
was present in the LE, stroma and glands, but by the evening of D4 IL1A staining was barely 369 
detectable, with only small sporadic patches of IL1A positive stromal cells visible on D5.  By D6 370 
no IL1A was apparent in either the LE or stroma.   371 
IL1B protein is only transiently expressed on the evening of D4 in Lif null uteri 372 
The cellular expression of IL1B was also investigated by immunohistochemistry in wt and Lif 373 
null mice on D4 and D5 of pregnancy (Fig 4).  These days were chosen based upon the RT-PCR 374 
analysis, showing that changes in expression of Il1b transcripts were greatest around the time of 375 
implantation.  On the morning of D4 of pregnancy, faint IL1B immunoreactivity was observed in 376 
the cells of the LE and GE in wt mice.  By the evening of D4, intense staining of IL1B was 377 
observed in the LE, GE and stromal cells and a similar pattern of expression was detected on D5, 378 
but the staining was of a lower intensity. In contrast, in Lif null mice, immunoreactive IL1B was 379 
predominantly observed in the cells of the luminal and glandular epithelia on the evening of D4 380 
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of pregnancy, although some faint staining was also evident in the sub-luminal stroma.  381 
Immunoreactive IL1B was not detected on D4 morning or D5 in Lif null uteri.  382 
Establishment of co-culture system 383 
Since our data suggested that the changing expression of IL1 and associated molecules is 384 
disrupted in the Lif null uterus, we investigated the effect of LIF on stromal and LE cells in vitro.  385 
For this purpose we used our co-culture system in which LE cells are grown on suspended 386 
membranes.  LE cells proliferated and formed a pavement-like epithelium on Cellagen 387 
membranes. They became confluent after 4 days of culture at which time the TER plateaued at or 388 
above 400Ω cm2 indicative of a tight junctional network.  The LE cells were immunostained for 389 
the tight junctional protein TJP1, and desmosomal protein, desmoplakin, together with 390 
cytoplasmicstaining for actin and examined by confocal microscopy demonstrated intact 391 
junctional complexes with neighbouring cells (Fig 5).   392 
 Influence of LIF on production of PTGES2 and IL1A by LE and stromal cells in vitro 
For co-culture experiments, uterine LE cells from D2 of pregnancy were cultured on Cellagen 393 
membranes with stromal cells in the culture well as described in methods (Fig 1).  Preliminary 394 
experiments using increasing concentrations of LIF showed that 50ng/ml LIF had a stimulatory 395 
effect on release of IL1Α  by LE cells into the apical compartment, an effect that was prevented 396 
when the LIF inhibitor (LIF05) was added to the medium (Fig 6). Subsequent experiments were 397 
carried out using this concentration of LIF.  LIF and/or the inhibitor were added to the culture 398 
media in both compartments and the medium was collected at 24 h and then every 48h up until 399 
120h and used for measurements of IL1A and PTGES2.   LIF significantly (p<0.01) increased 400 
secretion of both IL1Α and PTGES2 in the apical medium from the LE compartment of the co-401 
culture system at both 72 and 120 h while IL1A  was also increased at 24 h (Figs 7A and 8A).  402 
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By 120h in culture IL1A concentration increased more than twice in LIF cultures compared to 403 
inhibitor or LIF plus inhibitor cultures, while the PTGES2 concentration in cultures with LIF had 404 
tripled compared to all other groups. When the effect of LIF on the concentration of 405 
IL1Α  and PTGES2 was analysed in the lower chamber (adjacent to stromal cells), no significant 406 
difference was found during the entire culture (Figs 7B and 8B). In addition, LIF had no 407 
significant effect on IL1A production by LE cells cultured on membranes without co-cultured 408 
stromal cells (Figs 9A-B). However, LIF increased PTGES2 concentration only in the apical 409 
compartment of LE cells (Fig 9C) 410 
Effects of LIF on expression of mRNA for Il1a 411 
In order to assess effects of LIF on mRNA for Il1a LE cells and stromal cells were cultured in 412 
the co-culture system above and RNA extracted. Preliminary observations confirmed presence of 413 
Il1a mRNA in all cell types (data not presented). Semi-quantitative RT-PCR showed no 414 
differences between treatments after any of 2, 4 or 6 (data not shown) days of culture (Figure 415 
10A, B). 416 
Discussion 417 
LIF expression on D4 of pregnancy is critical for successful implantation [5;8] and in its absence 418 
the expression of a variety of molecules is affected in both the LE and stroma [7;8;11;33;46] 419 
reviewed in [10]. Uteri of Lif deficient mice are unable to support embryo implantation or to 420 
mount a decidual response [6]. However, the precise mechanisms by which LIF exerts its effects 421 
on implantation are still largely undefined.  The identification of LIF regulated molecules in the 422 
endometrium around the time of implantation will provide insights into the mechanisms that underlie 423 
uterine receptivity and decidualisation.  424 
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LIF is known to influence cells of the immune system [47; 48] in addition to cells in the 425 
reproductive tract. The cytokine IL1 and its associated molecules also play well established roles 426 
in inflammatory processes in the body [49]. Indeed the changes associated with implantation 427 
have been compared to an inflammatory reaction [50; 51].   Moreover several studies have 428 
suggested that IL1 expression is regulated by the local effects of estrogen and P4 and estrogen 429 
also regulates Lif [8;48].   430 
We found that components of the Il1 system are spatially and temporally regulated during the 431 
pre- and peri-implantation period. Abundant transcripts for Il1a, Il1b, Il1rn and Il1r2 were 432 
detected in the LE from both wt and Lif null uteri on D2 of pregnancy suggesting that at least at 433 
the transcript level, the ability of the Lif deficient mouse to induce a pro-inflammatory response 434 
in the early stages of pregnancy is not comprised.  However we have shown previously that the 435 
proportions and distribution of leukocytes, particularly macrophages and NK cells are already 436 
disrupted in Lif null uteri by day 3 of pregnancy [37].   437 
Increased transcript signals for Il1a, Il1b, Il1rn and Il1r1 and Il1r2 were observed in wt mice at 438 
the time of implantation on the evening of D4 of pregnancy in both LE and stroma.  These 439 
findings agree with previous studies where Il1a and Il1b mRNAs and their bioavailability were 440 
shown to peak between D4 and D5 of pregnancy [52].  Wood and colleagues [53] also reported 441 
that mRNA levels of uterine Il1a and Il1b decreased, from peak levels on D1 and D2, to very 442 
low levels on D3 of pregnancy but expression increased in the peri-implantation period.  We 443 
have further shown that Il1rn mRNA is consistently expressed up until the evening of D4 of 444 
pregnancy in the LE but barely detectable on D5 while stromal expression was uninterrupted, 445 
except for a transient loss of transcript on the morning of D4 of pregnancy. A similar pattern was 446 
observed for stromal Il1r2 transcripts.  That expression of Il1rn in the LE is continuous during 447 
 21
the pre- implantation phase suggests that IL1RN in the LE may play a role in inhibiting IL1 448 
receptor activation up until just after implantation has been initiated. In line with this, 449 
experiments have suggested that IL1 signalling is crucial to embryo implantation in vivo, as 450 
functional blockade of IL1R1 by repeated IL1RN administration i.p. from D3-D9 of pregnancy 451 
resulted in reduced implantation rates [28].  This inhibition of embryo implantation was 452 
attributed to a down regulation of integrins α4 and β3 on the LE by IL1RN [54]. However, 453 
Abbondanzo and co-workers [55] found administration of IL1RN to C57BL/6 X 129Sv hybrids 454 
had no effect on implantation. This difference may have a methodological source but it casts 455 
uncertainty on the absolute requirement for IL1 signalling for implantation.  Our data suggest 456 
that IL1 signalling is likely to be functional in the later stages of implantation 457 
Since activation of the IL1R2 by any IL1 ligand does not elicit a biological response, it is 458 
proposed to function by limiting the bioavailability of IL1A and IL1B by acting as a decoy 459 
receptor; reducing the amount of free IL1 [56; 57].  Examination of Il1r2 mRNA levels in the wt 460 
peri-implantation uterus revealed that stromal transcript expression of Il1r2 was low with 461 
detection only on d3, d4pm and d5 and only d3 and d5 in the null stroma. In contrast LE extracts 462 
on D2-D6 of pregnancy consistently gave bands both in wt and null animals. Therefore, 463 
transcriptional regulation of stromal Il1r2 during the peri-implantation period may play a role in 464 
regulating the bioavailability of IL1A and IL1B but it is little affected by LIF.   465 
The spatio-temporal expression of several components of the IL1 system in the Lif null uterus 466 
was altered from that of wt uteri from D3 of pregnancy onwards.  Transcripts for Il1a in the LE 467 
from Lif null uteri were low except for a strong band on D2, in contrast to wt LE, where signal 468 
for Il1a was high on the evening of D4 of pregnancy following the nidatory burst of LIF 469 
expression. This suggests that LIF does either directly or indirectly regulate Il1a over the peri-470 
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implantation period. Stromal expression of Il1a mRNA in the nulls was restricted to D3 and D5 471 
suggesting major misregulation in transcriptional timing.   472 
Interestingly PCR signal for Il1rn in the Lif null LE similarly declined from D2 onwards, with 473 
barely detectable signal by D4-D5.  The low levels of Il1rn in the uteri of Lif null compared to wt 474 
mice could contribute to the implantation defect. The premature reduction in antagonism of IL1A 475 
and IL1B may result in over-stimulation of the IL1 signalling cascade potentially altering the 476 
inflammatory response [20].  Huang and colleagues [58] postulated that an appropriate ratio of 477 
IL1 to IL1RN is crucial during embryo implantation.  Furthermore, work from our laboratory has 478 
shown that both macrophage number and distribution (a primary source of IL1) were altered in the 479 
uteri of Lif deficient mice from D3 of pregnancy compared to wt [37].  It has also been confirmed in 480 
the present study that IL1 is synthesised in luminal and probably glandular epithelium as well as 481 
stromal cells, and that leukocytes are by no means the only source of IL1 ligands in the pre-482 
implantation uterus.  Surprisingly, there were no significant differences between the expression of 483 
Il1b transcripts in the uteri of wt and Lif null mice, indicating that the strong Il1b bands seen on 484 
the evening of D4 are not a direct result of LIF production on D4.   485 
No significant alterations were observed in the gene expression of Il1r1 or Il1r2 between uterine 486 
LE of wt and Lif null mice during early pregnancy in the LE suggesting these receptors are not 487 
regulated by LIF. However null stromal Il1r1 was expressed in a pattern at variance with that in 488 
wt, with loss of transcripts 12-24 h after the known peak of Lif expression in wt animals. Lack of 489 
proper regulation of epithelial derived IL1A in the Lif null uterus may lead secondarily to lack of 490 
IL1B in the glands observed by immunocytochemistry on day 5. This may reflect a failure of 491 
normal LE to stromal signalling. Indeed, it is likely that the stromal misexpression of several Il1 492 
components in the uteri of Lif null mice compared to wt may be partly attributed to the lack of 493 
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secondary signalling between unstimulated LE and the stroma in the null uteri, particularly on 494 
D4 or D5. 495 
On D3 of pregnancy in both wt and Lif null uteri, immunoreactive IL1A was detected in the LE, 496 
GE and some stromal cells.  IL1A positive cells within the stroma appeared larger than other 497 
stromal cells and may represent IL1A producing immune cells such as macrophages but it was 498 
not possible to confirm this definitively because of the differnences in fixation requirement of the 499 
various antibodies.  Previous studies by our laboratory have shown that there are increasing 500 
numbers of macrophages at this time which are known to be one of the major producers of IL1 501 
[37].  Intense staining of IL1A was observed in the decidua on D5 and D6 of pregnancy but 502 
markedly reduced in Lif null uteri from the morning of D4 onwards. Since these animals lack 503 
decidualisation and IL1 is known to induce decidualising molecules [30; 31] the lack of IL1A 504 
here is consistent with it being a mediator of LIF induced decidualisation.  In vitro studies in 505 
murine endometrial stromal cells have also shown that the ECM glycoprotein tenascin C (TNC) 506 
expression is upregulated by Il1a [7; 59].  Similarly, TNC has also been shown to be absent from 507 
the site of implantation in the uteri of Lif null mice during the implantation period [7]. However, 508 
whilst evidence suggests a fundamental role for IL1 signalling in embryo implantation, gene 509 
deletion experiments in mice have revealed that there are no overt reproductive phenotypes in 510 
mice lacking either Il1r1 or Il1b [60-62].  Various members of the IL1 system have been 511 
identified in the uterus including novel ligands namely IL1F5 and IL1F7 [63] but to date they 512 
have no identifiable function.  Perhaps the lack of overt phenotypes in the gene deleted mice can 513 
be explained by compensatory effects of these and other novel ligands or receptors.    514 
In order to obtain functional evidence for the interrelationship of IL1 and LIF we co-cultured LE 515 
with stromal cells to examine the influence of LIF in a system which more closely mimics the 516 
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physiological relationship of these two cell layers than separate culture. A surprising result here 517 
was that the predominant secretion of IL1 induced by LIF in our in vitro culture system is 518 
directed towards the lumen, a location removed from potential tissue targets.  However it is 519 
possible that this molecule is involved in leucocyte recruitment to the point of possible pathogen 520 
entry from luminal fluids.  This would seem logical since the LE barrier is breached during 521 
implantation with potential risk of infection.   522 
LIF stimulated IL1Α secretion by LE cells in a dose dependent manner, an effect that was 523 
abrogated by an established LIF inhibitor. It did not stimulate IL1A secretion by the basal 524 
stromal cells. Expression of Il1a mRNA in cultured LE (by semi-quantitative PCR) did not 525 
appear to be affected by adding LIF to medium, or by LIF inhibition. Therefore, stimulation of 526 
secretion of this cytokine into the culture medium by LIF is likely to occur post transcriptionally 527 
at the level of protein synthesis or of the secretory apparatus. These would be consistent with an 528 
effect of the inhibitor by 24 h. Stimulation of IL1 secretion by LIF is in keeping with the 529 
increased protein seen by immunohistochemistry. Thus, this is an additional level of LIF 530 
regulation of IL1A to the regulation of LE Il1a transcription in vivo, inferred from the rapid loss 531 
of PCR signal after D2 of pregnancy in Lif null LE. The lack of direct transcript regulation in 532 
culture suggests that, in vivo, regulation may be indirect and/or on mRNA stability.  533 
Alternatively, direct transcript stimulation may be prevented under our co-culture conditions.  534 
 
LIF also induced release of PTGES2 by LE cells in co-culture, an effect which was also 535 
observed in culture of LE alone.  In the co-culture system, LE and stromal cells are able to 536 
establish a dialogue, resulting in modulation of cytokine production [64], thus making this model 537 
more physiologically relevant.  Jacob and Carson [30] reported that IL1 induces PTGES2 538 
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secretion by uterine stromal cells in vitro. This effect is mediated through upregulation of Ptgs2 539 
mRNA in stromal cells [32; 65].  Moreover uterine secretion of IL1Α by epithelial cells increases 540 
PTGS2 enzyme activity [66-68]. We have previously reported defects in PTGS2 protein 541 
expression and decidualisation of uterine stroma cells in Lif null mice [7]. We have also shown 542 
that LIF does not stimulate PTGES2 by stromal cells cultured without LE [34]. However, since 543 
LIF does not directly promote the secretion of PTGES2 by uterine stromal cells in vitro, 544 
PTGES2 is not likely to be a direct target of LIF in the stroma [34].  LIF may exert its effect 545 
mainly though upregulation of intermediate messengers in the LE that in turn regulate 546 
decidualisation. It is unlikely that IL1A from LE acts directly on stromal cells per se since our 547 
results suggest it is secreted mainly apically.  However IL1A from GE and/or other cells in the 548 
stroma may regulate stromal PTGS2 in vivo and thus contribute to decidualisation and 549 
angiogenesis.  Furthermore, autocrine activation of IL1R1 signalling pathways in the LE is 550 
likely. This may contribute to LE receptivity and susceptibility to embryonic signals that in turn 551 
directly or indirectly initiate the decidual response. It should not be forgotten that the embryo 552 
itself expresses IL1A [69-70 and this study], which could also interact locally with LE. Moreover 553 
IL1 is known to affect the phenotype of invasive trophoblast in human [71-73] and mouse [74] 554 
so one target of apically secreted IL1 could be the trophoblast as well as a possible 555 
immunomodulatory one, mentioned above. 556 
In LE cells LIF may induce PTGES2 production through an autocrine influence of IL1 via the 557 
IL1 receptor. This may also activate basally released modulators of stromal cells to contribute to 558 
the decidual response following signalling from the embryo. In addition, LIF modulates IL1 559 
signalling by regulating IL1RN in the LE to dampen both the autocrine effect and any paracrine 560 
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influence on the blastocyst. Our results confirm the extreme complexity of the interacting 561 
network of secreted molecules which regulate implantation related events.  562 
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Figure Legends 
Figure 1. Schematic presentation of co-culture system. Mouse uterine luminal epithelial (LE) 
cells were cultured on the suspended Cellagen membrane, stroma cells were cultured on the base 
of the wells in a 24-well culture dish. 
Figure 2. Gene expression analysis of the Il1 associated proteins in the peri-implantation uterus 
of wt and Lif null mice.  mRNAs were prepared separately from LE and stroma of wt and Lif null 
uteri on the required days of pregnancy.  RT-PCRs were performed for (A) Il1a, (B) Il1b, (C) 
Il1rn, (D) Il1r1 and (E) I1r2.  (F) Gapdh.  Negative controls consisting of no template (water 
only) and no reverse transcriptase (-RT) were assembled in parallel in each experiment (final two 
columns).   
Figure 3. Immunolocalisation of IL1A during early pregnancy. Immunofluorescence detection of 
IL1A (green) in paraffin embedded uterine sections on D3-D6 of pregnancy in wt and Lif null 
females.  Note that the overall expression of IL1A is reduced in the Lif null uterus compared to 
wt.  Strong signals were also apparent in the embryo on D5 of pregnancy in wt mice.  Scale bars 
represent 100µm.  LE = luminal epithelium, S= stroma, E = embryo, G= glands. 
Figure 4.  Immunolocalisation of IL1B in the peri-implantation uterus from wt and Lif null mice.  
Detection of IL1B was performed on paraffin embedded uterine sections from wt and Lif null 
mice on D4 and D5 of pregnancy by immunohistochemistry.  Cytoplasmic staining of IL1B 
(brown) can be seen in the LE, stroma and uterine glands of the wt mouse.  In contrast, IL1B 
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immunoreactivity was only evident in the uteri of Lif null mice on D4 evening (2000-2200h).  
All nuclei were counterstained with haematoxylin (blue).  Scale bars represent 100µm. 
LE=luminal epithelium, S=stroma, G = glands, E = embryo and L = lumen.  
Figure 5. Confocal microscopic analysis of junctional proteins in the cultured luminal epithelium 
(LE) cells. LE cells cultured on Cellagen membranes were stained for tight junction proteins  
TJP1 and desmoplakin protein (11.5F) (green) and also the nuclear stain Hoescht (blue) and 
Texas red-conjugated phalloidin (red). A single optical section is shown. Note high number of 
binuclear LE cells. Scale bar = 20 μm. 
Figure 6. Effects of LIF on production of IL1A by murine endometrial luminal epithelial (LE) 
cells co-cultured with stromal cells. In preliminary experiments, LE cells were cultured on 
Cellagen membranes in the absence (control) or presence of increasing concentrations of LIF 
with stromal cells on the floor of the wells. LIF inhibitor was also supplemented in a ten fold 
excess to the concentration of LIF. Concentration of IL1Α in culture media increased in a dose 
dependent manner. The data represent average ± S.E.M. in three separate replicates. Treatments 
marked with different number of asterisks are significantly different from each other. * vs 
**p<0.05. LIF + Inh = 50ng/ml LIF + 500ng/ml inhibitor.  
Figure 7. Effects of LIF on production of IL1Α by co-cultured murine endometrial cells. Luminal 
epithelial (LE) cells were cultured on Cellagen membranes placed in the wells of 24 well plates 
and the stromal cells were cultured on the bottom of the culture wells. A) Concentration of IL1A 
in the LIF-treated LE culture media (apical compartment) increased significantly with time in 
culture. B) No significant differences were observed in the concentration of IL1Α in stromal 
culture media (basal) between treatments. The data represent average ± S.E.M. in three separate 
replicates. At each time point treatments marked with different number of asterisks are 
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significantly different from each other. * vs ** p<0.05, * vs. *** p<0.01, ** vs. ***p<0.05, **** 
vs. *** p<0.05, **** vs. ** p<0.01, **** vs. * p<0.01. LIF + Inh = 50ng/ml LIF + 500ng/ml 
inhibitor. 
Figure 8. Effects of LIF on production of PTGES2 by co-cultured murine endometrial cells. 
Luminal epithelial (LE) cells were cultured on Cellagen membrane and the stromal cells were 
cultured on the bottom of the culture wells. A) LIF increased concentration of PTGES2 in the LE 
culture media (apical) with time in culture. B) No differences were observed in the concentration 
of PTGES2 in stroma culture media (basal) between treatments after 24 and 72 h of culture but 
there was a significant increase compared to other groups at 120h. The data represent average ± 
S.E.M. in three separate experiments. At each time point treatments marked with different 
number of asterisks are significantly different from each other. * vs.*** p<0.05, **vs. *** 
p<0.05, * vs. **** p<0.01, ** (both control and LIF + Inh treatments at 120h) vs. **** p<0.05. 
LIF + Inh = 50ng/ml LIF + 500ng/ml inhibitor. 
Figure 9. Effects of LIF on production of IL1Α and PTGES2 by murine endometrial luminal 
epithelial (LE) cells cultured alone. LE cells were cultured on the insert Cellagen membrane in 
the absence (control) or presence of 50ng/ml LIF. No differences were observed in the 
concentrations of IL1Α between apical (A) and basal (B) culture media or in the presence or 
absence of LIF.  Similarly, no differences were observed in the concentration of PTGES2 in the 
basal media (D).  However, LIF increased PTGES2 concentrations in the apical compartment at 
72 and 120 hrs (C) (p<0.05). Data represents average ± S.E.M. in three separate experiments in 
each case. 
Figure 10. Effects of LIF on expression of mRNA for Il1a in murine endometrial cells.  Total 
RNA was extracted from either of freshly collected and cultured stromal and LE cells.  A) Semi-
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quantitative analysis of mRNA for Il1a in LE and stroma cells after 6 days of culture in the 
absence (control) or presence of LIF or LIF inhibitor. No differences were observed in the 
intensity of bands for Il1a mRNA among treatments. B) Semi-quantitative analysis of changes in 
the expression of mRNA for Il1a in LE cells in relation to time of culture. LIF + Inh = 50ng/ml 
LIF + 500ng/ml inhibitor. 
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TABLE 1. 
 
Primer set Sequence  (5’-3’) Cycle number 
Product 
size 
(bp) 
Optimized 
annealing 
temp (°C) 
Accession no./ 
reference 
Actb (f) AAACTGGAACGGTGAAGGC 
Actb (r) CCTGGGCCATTCAGAAATTA 30 192 60 X03672 
Gapdh (f)  TCTGAGGGCCCACTGAAG 
Gapdh (r) AGGGTTTCTTACTCCTTGGAGG 28 220 60 NM008084 
Il1r1 (f)  AAATAATGAGTTACCCGAGGTCCAGTGG 
Il1r1 (r) AGGCATCGTATGTCTTTCCATCTGAAGC 30 709 60 NM008362 
Il1a (f)  CAAACTGATGAAGCTCGTCA 
Il1a (r)  TCTCCTTGAGCGCTCACGAA 32 220 60 NM010554 
Il1b (f)  ATGGCAACTGTTCCTGAACTCAACT 
Il1b (r) CAGGACAGGTATAGATTCTTTCCTTT 
32 563 60 NM008361 
Il1r2 (f) GCATCATTGGGGTCAAGACT 
Il1r2 (r) TGAGTACTGGGGGTGTAGCC 32 156 60 BC032962 
Il1rn (f) TAGCAAATGAGCCACAGACG 
Il1rn (r) ACATGGCAAACAACACAGGA 32 190 60 NM031167 
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